DrugPatentWatch Database Preview
Drugs in Development Information for Mirodenafil
» See Plans and Pricing
What is the drug development status for Mirodenafil?
Mirodenafil is an investigational drug.
There have been 4 clinical trials for Mirodenafil.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Renal Insufficiency, Kidney Diseases, and Erectile Dysfunction. The leading clinical trial sponsors are SK Chemicals Co.,Ltd., Asan Medical Center, and Janssen Korea, Ltd., Korea.
There are thirteen US patents protecting this investigational drug and one hundred and sixty-seven international patents.
Summary for Mirodenafil
| US Patents | 13 |
| International Patents | 167 |
| US Patent Applications | 60 |
| WIPO Patent Applications | 62 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2011-11-01) |
| Vendors | 27 |
Recent Clinical Trials for Mirodenafil
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg | SK Chemicals Co.,Ltd. | Phase 1 |
| Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg | SK Chemicals Co.,Ltd. | Phase 1 |
| A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction | Janssen Korea, Ltd., Korea | Phase 4 |
Clinical Trial Summary for Mirodenafil
Top disease conditions for Mirodenafil
Top clinical trial sponsors for Mirodenafil
US Patents for Mirodenafil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Mirodenafil | Start Trial | Treatment of erectile dysfunction and other indications | Strategic Science & Technologies, LLC (Cambridge, MA) | Start Trial |
| Mirodenafil | Start Trial | Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods | Indiana University Research and Technology Corporation (Indianapolis, IN) United States Government as Represented by the Department of Veterans Affairs (Washington, DC) | Start Trial |
| Mirodenafil | Start Trial | Pyrrolopyrimidinone derivatives, process of preparation and use | SK Chemicals Co., Ltd. (Suwon, KR) In2Gen Co., Ltd. (Seoul, KR) | Start Trial |
| Mirodenafil | Start Trial | Composition for reducing skin wrinkles including PDE5 inhibitor | SK CHEMICALS CO., LTD. (Seongnam, Gyeonggi-Do, KR) | Start Trial |
| Mirodenafil | Start Trial | Methods and compositions for oral administration of melanocortin receptor agonist compounds | Start Trial | |
| Mirodenafil | Start Trial | Treatment of erectile dysfunction and other indications | Strategic Science & Technologies, LLC (Cambridge, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Mirodenafil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Mirodenafil | Australia | AU2009348470 | 2029-06-24 | Start Trial |
| Mirodenafil | Australia | AU2015203547 | 2029-06-24 | Start Trial |
| Mirodenafil | Australia | AU2016200596 | 2029-06-24 | Start Trial |
| Mirodenafil | Australia | AU2017206223 | 2029-06-24 | Start Trial |
| Mirodenafil | Australia | AU2019200847 | 2029-06-24 | Start Trial |
| Mirodenafil | Brazil | BRPI0925099 | 2029-06-24 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
